M Harano

Summary

Affiliation: Kurume University School of Medicine
Country: Japan

Publications

  1. ncbi Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka
    M Harano
    Institute of Brain Diseases, Kurume University School of Medicine, Japan
    Kurume Med J 44:201-8. 1997
  2. ncbi A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis
    M Harano
    Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Ann N Y Acad Sci 1025:307-15. 2004
  3. ncbi No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence
    A Morio
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:411-7. 2006
  4. ncbi Association study between casein kinase 1 epsilon gene and methamphetamine dependence
    T Kotaka
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
    Ann N Y Acad Sci 1139:43-8. 2008
  5. ncbi Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence
    A Nomura
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:116-24. 2006
  6. ncbi Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis
    H Ujike
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:90-6. 2006
  7. ncbi Antagonistic effects of beta-phenylethylamine on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release from rat striatal slices
    S Yamada
    Institute of Brain Diseases, School of Medicine, Kurume University, Fukuoka, Japan
    Eur J Pharmacol 343:145-50. 1998
  8. ncbi Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis
    H Ujike
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
    Pharmacogenomics J 3:242-7. 2003
  9. ncbi Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety
    S Yamada
    Institute of Brain Diseases, Kurume University School of Medicine, Japan
    Int Clin Psychopharmacol 13:213-7. 1998
  10. ncbi Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum
    S Yamada
    Institute of Brain Diseases, Kurume University School of Medicine, Kurume, Japan
    J Pharmacol Exp Ther 291:994-8. 1999

Collaborators

Detail Information

Publications15

  1. ncbi Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka
    M Harano
    Institute of Brain Diseases, Kurume University School of Medicine, Japan
    Kurume Med J 44:201-8. 1997
    ..These findings indicate that the frequency of the Cys311 is biased geographically and that this must considered when investigating the occurrences of genetic variants and diseases...
  2. ncbi A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis
    M Harano
    Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Fukuoka, Japan
    Ann N Y Acad Sci 1025:307-15. 2004
    ..It is suggested that in methamphetamine psychosis the TaqI A polymorphism not only regulates prolongation of psychosis symptoms but also influences the form of the temporal lobe...
  3. ncbi No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence
    A Morio
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:411-7. 2006
    ..The present findings suggest that the CART gene may not play a pivotal role in the development of METH dependence and psychosis, at least in a Japanese population...
  4. ncbi Association study between casein kinase 1 epsilon gene and methamphetamine dependence
    T Kotaka
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
    Ann N Y Acad Sci 1139:43-8. 2008
    ..The present findings suggest that having a genetic variant of the CSNK1E gene did not affect susceptibility to methamphetamine dependence or psychosis, at least in a Japanese population...
  5. ncbi Association study of the tumor necrosis factor-alpha gene and its 1A receptor gene with methamphetamine dependence
    A Nomura
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:116-24. 2006
    ..These results suggest that genetic variations in the TNF-alpha gene and its receptor genes may not be involved in individual vulnerability to METH dependence...
  6. ncbi Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis
    H Ujike
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Ann N Y Acad Sci 1074:90-6. 2006
    ..These findings indicate that a genetic variant of the DRP-2 gene may not affect the risk of METH psychosis or any clinical phenotype of the disorder...
  7. ncbi Antagonistic effects of beta-phenylethylamine on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release from rat striatal slices
    S Yamada
    Institute of Brain Diseases, School of Medicine, Kurume University, Fukuoka, Japan
    Eur J Pharmacol 343:145-50. 1998
    ..3 micromol/l beta-phenylethylamine. These data indicate that submicromolar levels of beta-phenylethylamine could modify the dopamine autoreceptor mediated changes in evoked dopamine release from rat striatal slices...
  8. ncbi Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis
    H Ujike
    Department of Neuropsychiatry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
    Pharmacogenomics J 3:242-7. 2003
    ..0054, OR=4.24, 95% CI=2.46-7.31). The present study demonstrated that the presence of nine- or fewer repeat alleles of hDAT1 is a strong risk factor for a worse prognosis of METH psychosis...
  9. ncbi Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety
    S Yamada
    Institute of Brain Diseases, Kurume University School of Medicine, Japan
    Int Clin Psychopharmacol 13:213-7. 1998
    ..These results indicate that the free saliva MHPG level may be a useful indicator for assessing not only the level of anxiety, but also the response to drug treatment for anxiety in these patients...
  10. ncbi Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum
    S Yamada
    Institute of Brain Diseases, Kurume University School of Medicine, Kurume, Japan
    J Pharmacol Exp Ther 291:994-8. 1999
    ....
  11. ncbi Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder
    T Nishiyama
    Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan
    Pharmacogenomics J 5:89-95. 2005
    ..This finding partly replicates a recent case-control study of GABRG2 in METH use disorder, and thus indicates that GABRG2 may be one of the susceptibility genes of METH use disorder...
  12. ncbi Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms
    S Ide
    Division of Psychobiology, Tokyo Institute of Psychiatry, Tokyo, Japan
    Pharmacogenomics J 6:179-88. 2006
    ..There was also a significant association between IVS2+G691C and patients with transient psychosis. These results suggest that the OPRM1 gene variations may be a factor in development and prognosis of MAP psychosis...
  13. ncbi No association is found between the candidate genes of t-PA/plasminogen system and Japanese methamphetamine-related disorder: a collaborative study by the Japanese Genetics Initiative for Drug Abuse
    N Iwata
    Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
    Ann N Y Acad Sci 1025:34-8. 2004
    ..This study suggests that t-PA/plasminogen system is unlikely to be a major contributor to the substance abuse liability and/or the development of MAP psychosis...
  14. ncbi No association found between the type 1 sigma receptor gene polymorphisms and methamphetamine abuse in the Japanese population: a collaborative study by the Japanese Genetics Initiative for Drug Abuse
    T Inada
    Department of Psychiatry and Psychobiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Ann N Y Acad Sci 1025:27-33. 2004
    ..This study suggests that type 1 sigma receptor gene is unlikely to play a major role in substance abuse liability and/or the development of MAP psychosis...
  15. ncbi Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
    M Ikeda
    Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan
    Genes Brain Behav 6:107-12. 2007
    ..However, no interaction was seen in our samples. This is the first association analysis of ARRB2, and our results indicate that ARRB2 may play a role in the pathophysiology of METH use disorder...